Pilot Study to Determine the Immunogenicity of Immucothel® and Oral Tolerance Induction With Biosyn Native KLH in Healthy Subjects (ITN047AI)
Phase of Trial: Phase 0
Latest Information Update: 15 Apr 2016
At a glance
- Drugs Keyhole limpet haemocyanin (Primary) ; Adjuvants
- Indications Cancer
- Focus Pharmacodynamics
- 11 Mar 2016 Time frame for primary end points has been revised.
- 27 Dec 2013 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to discontinued.
- 03 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.